Science

News
Jennie Durant
Dec. 9, 2023
‘Inert’ ingredients in pesticides may be more toxic to bees than scientists thought
Pesticide users sometimes know very little about how inerts function. That’s partly because they are regulated very differently than active ingredients.
Read More

More in Science

Untangling the genetics that underlie our facial features
Feature

Untangling the genetics that underlie our facial features

Dec. 2, 2023

After turning up hundreds of genes with hard-to-predict effects, some scientists are now probing the grander developmental processes that shape face geometry.

From the journals: JLR
Journal News

From the journals: JLR

Dec. 1, 2023

A safer combination therapy for liver disease. A mechanistic pathway of the pathophysiology of NASH. A novel therapeutic target for heart failure. Read about recent papers on these topics.

Insulin injections could one day be replaced with rock music
News

Insulin injections could one day be replaced with rock music

Nov. 26, 2023

Using mice, researchers engineered cells to release insulin in response to specific sound waves: the music of the band Queen.

From the journals: JBC
Journal News

From the journals: JBC

Nov. 24, 2023

Protein cleavage in polycystic kidney disease. Expanding tools to study ion channels. Mechanisms of 5-fluorouracil cytotoxicity and chemoresistance. Read about papers on these topics.

Detecting biomarkers for deadly lung disease
Journal News

Detecting biomarkers for deadly lung disease

Nov. 21, 2023

A group led by scientists from Genentech Inc is studying whether bioactive lipid species can predict idiopathic pulmonary fibrosis progression.

ASBMB journal events at #DiscoverBMB
Annual Meeting

ASBMB journal events at #DiscoverBMB

Nov. 21, 2023

The Journal of Biological Chemistry, the Journal of Lipid Research and Molecular & Cellular Proteomics are a big part of the society, so naturally they will be center stage in San Antonio.

News

FDA approves CRISPR–Cas9 therapy for sickle cell disease

The gene editing treatment from Vertex Pharmaceuticals and CRISPR Therapeutics is the first of its kind.
FDA approves CRISPR–Cas9 therapy for sickle cell disease

More in Science

Vampire viruses prey on other viruses to replicate themselves
News

Vampire viruses prey on other viruses to replicate themselves

Nov. 18, 2023

And they may hold the key to new antiviral therapies.

From the journals: MCP
Journal News

From the journals: MCP

Nov. 17, 2023

A new enzyme is unlocked in bacterial photosynthesis. A molecular target for alcohol consumption is uncovered. A special issue offers new perspectives in ECM research. Read about these recent papers.

Understanding the cause of childhood Alzheimer's
Health Observance

Understanding the cause of childhood Alzheimer's

Nov. 16, 2023

Today is World Sanfilippo Awareness Day.

Today is International 15q Day
Health Observance

Today is International 15q Day

Nov. 15, 2023

Take some time to read up on the three conditions that constitute this class of neurodevelopmental disorders.

Receptor regulation clues may scratch an itch
Journal News

Receptor regulation clues may scratch an itch

Nov. 14, 2023

Thomas Sakmar’s lab found that a GPCR associated with a liver disease symptom is regulated in previously unknown ways, possibly leading to new therapies.

The promise of AI in precision medicine and immunotherapy for diabetes
Health Observance

The promise of AI in precision medicine and immunotherapy for diabetes

Nov. 14, 2023

Today is World Diabetes Day. To mark this observance, this article covers the many ways in which diabetes research and drug development stands to benefit from the use of AI.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.